BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2020 related articles for article (PubMed ID: 19558249)

  • 1. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and economic outcomes of pharmacist-managed antiepileptic drug therapy.
    Bond CA; Raehl CL
    Pharmacotherapy; 2006 Oct; 26(10):1369-78. PubMed ID: 16999646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections.
    MacLaren R; Bond CA; Martin SJ; Fike D
    Crit Care Med; 2008 Dec; 36(12):3184-9. PubMed ID: 18936700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.
    Bond CA; Raehl CL
    Pharmacotherapy; 2006 Jun; 26(6):735-47. PubMed ID: 16716127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the impact of a tele-ICU pharmacist on the management of sedation in critically ill mechanically ventilated patients.
    Forni A; Skehan N; Hartman CA; Yogaratnam D; Njoroge M; Schifferdecker C; Lilly CM
    Ann Pharmacother; 2010 Mar; 44(3):432-8. PubMed ID: 20164471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and resource utilization associated with laparoscopic and open colectomy using a large national database.
    Delaney CP; Chang E; Senagore AJ; Broder M
    Ann Surg; 2008 May; 247(5):819-24. PubMed ID: 18438119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and length-of-stay outcomes, 1993-2003, in the binational Australian and New Zealand intensive care adult patient database.
    Moran JL; Bristow P; Solomon PJ; George C; Hart GK;
    Crit Care Med; 2008 Jan; 36(1):46-61. PubMed ID: 18090383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical care pharmacy services in United States hospitals.
    Maclaren R; Devlin JW; Martin SJ; Dasta JF; Rudis MI; Bond CA
    Ann Pharmacother; 2006 Apr; 40(4):612-8. PubMed ID: 16569803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates.
    Bond CA; Raehl CL
    Pharmacotherapy; 2007 Apr; 27(4):481-93. PubMed ID: 17381374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A primer on critical care pharmacy services.
    Erstad BL
    Ann Pharmacother; 2008 Dec; 42(12):1871-81. PubMed ID: 19017823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of anemia in critically ill patients: analysis of a database of 139 hospitals.
    Dasta J; Mody SH; McLaughlin T; Leblanc J; Shen Y; Genetti M; Raut MK; Piech CT
    Am J Ther; 2008; 15(5):423-30. PubMed ID: 18806517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a multiple-site intensive care unit telemedicine program on clinical and economic outcomes: an alternative paradigm for intensivist staffing.
    Breslow MJ; Rosenfeld BA; Doerfler M; Burke G; Yates G; Stone DJ; Tomaszewicz P; Hochman R; Plocher DW
    Crit Care Med; 2004 Jan; 32(1):31-8. PubMed ID: 14707557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of a clinical pharmacist on a neurosurgical team.
    Weant KA; Armitstead JA; Ladha AM; Sasaki-Adams D; Hadar EJ; Ewend MG
    Neurosurgery; 2009 Nov; 65(5):946-50; discussion 950-1. PubMed ID: 19834408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions.
    MacLaren R; Brett McQueen R; Campbell J
    Pharmacotherapy; 2013 Apr; 33(4):401-10. PubMed ID: 23468188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality rates under the care of junior and senior surgery residents in a surgical intensive care unit/neurologic intensive care unit: a 5-year retrospective cohort study at Taoyuan Armed Forces General Hospital.
    Lee MT; Hu P; Hsi SC; Liu KY; Chao HM; Chen YQ
    J Crit Care; 2008 Dec; 23(4):550-5. PubMed ID: 19056021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and impact of aspiration pneumonia in patients undergoing surgery in Maryland, 1999-2000.
    Kozlow JH; Berenholtz SM; Garrett E; Dorman T; Pronovost PJ
    Crit Care Med; 2003 Jul; 31(7):1930-7. PubMed ID: 12847385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of patients before transfer to a tertiary care intensive care unit: impact on outcome.
    Gerber DR; Schorr C; Ahmed I; Dellinger RP; Parrillo J
    J Crit Care; 2009 Mar; 24(1):108-13. PubMed ID: 19272546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 101.